The Health Department plans to cover 1,24,215 women under the HPV-DNA testing programme.
Tamil Nadu is all set to implement HPV-DNA testing for cervical cancer in the five high-burden districts of Dharmapuri, Villupuram, Tiruvannamalai, Perambalur and Ariyalur in the first phase. The Health department plans to cover 1,24,215 women under the HPV-DNA testing programme.
In an order issued recently, the State government accorded permission to the Mission Director, National Health Mission (NHM), Tamil Nadu, to implement the programme, which was one of the announcements made by the Chief Minister in the Assembly early this year.
NHM had sent a proposal to the State government to implement the HPV-DNA testing programme for cervical cancer among women under the Tamil Nadu Cancer Care Mission. According to the Tamil Nadu Cancer Registry Project 2023 report, 87,156 new cancer cases - 37,931 among men and 49,225 among women - were reported in Tamil Nadu in 2023. The projected number of new cancer cases for 2026 is around one lakh (94,098), it said.
Cervical cancer remains an important cause of morbidity and mortality among women in Tamil Nadu, despite being largely preventable through vaccination, effective screening, early identification of precancerous lesions and timely treatment, it said, adding that Tamil Nadu has been implementing screening for the three common cancers - breast, cervical and oral cancers - at the institutional level since 2012. Screening for cervical cancer was predominantly carried out using Visual Inspection with Acetic Acid. Population-based screening for common Non Communicable Diseases and Organised Cancer Screening Programme was also implemented in the State.
HPV-DNA testing, it said, provides an objective and highly sensitive method for identifying women at risk of cervical pre-cancer and cancer. It has the advantages of high sensitivity, reproducibility and high negative predictive value. Hence, it is recommended as a primary screening modality by the World Health Organization. The WHO Regional Implementation Framework for elimination of cervical cancer emphasising the 90-70-90 targets, includes screening of 70% of women with a high-performance test by 35 years of age and again by 45 years of age. Therefore, the introduction of HPV-DNA testing as a primary screening modality is proposed to strengthen the existing cervical cancer screening programme in Tamil Nadu, it said.
The Mission Director said that the government of India has approved ₹869.50 lakh in NHM Record of Proceedings 2026-2027 under the category State-specific initiatives and innovations for the implementation of HPV-DNA testing for cervical cancer among women of 35 years of age. The estimated expenditure towards testing at an indicative cost of ₹700 per test works out to ₹8,69,50,500, the order said. The initiative will be expanded to other districts in a phased manner based on the approval of the government of India.
Published - November 17, 2026 07:41 pm IST
Source: The Hindu · The Hindu Bureau
At a glance
- Topic
- World
- Country
- 🇮🇳 IN
- Publisher language
- EN
- Added to Allnira